Every 8-K that Sono-Tek Corporation (SOTK) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow SOTK and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full SOTK filings page.
Sono-Tek Corporation reported fiscal second-quarter and first-half 2027 results for periods ended August 31, 2026. First-half net sales were $10,893,312, up 6% year over year; gross margin was 55%, versus 51%. Operating income rose 41% to $1,278,692, and net income increased 22% to $1,107,462. Medical-market sales climbed 289% to $7,050,000, led by balloon-coating and specialty stent-coating systems.
Second-quarter net sales increased 1% to $5,232,153, while operating income declined 9% to $381,531 and net income declined 14% to $366,294. Alternative Energy sales decreased 85% to $855,000 in the first half; Sono-Tek attributed the decline to shifts in U.S. government policy and spending in that sector. Management reiterated its expectation of flat to modest revenue growth for fiscal 2027, citing the timing of several large, higher-value production platform orders, which can increase quarter-to-quarter variability as these systems become a larger portion of the business. It said recent new record orders significantly increase revenue visibility for fiscal 2028. Cash and cash equivalents were $10,249,779 as of August 31, 2026.
Sono-Tek Corporation (SOTK) reported results of its annual meeting of shareholders held on August 20, 2026. Shareholders elected three directors: Eric Haskell (4,820,731 votes for, 323,232 against, 6,483,666 broker non-votes), Adeniyi Lawal (5,009,487 for, 134,476 against, 6,483,666 broker non-votes), and Carol O’Donnell (4,837,468 for, 306,495 against, 6,483,666 broker non-votes). Other directors whose terms run through August 2027 continue to serve on the board. Shareholders also voted on another matter that received 11,611,748 votes for, 13,467 against and 2,414 abstentions, with no broker non-votes. Sono-Tek furnished, but did not file, an investor presentation from the annual meeting as Exhibit 99.1 under Items 2.02 and 7.01.
Sono-Tek Corporation reported strong first quarter fiscal 2027 results with higher sales, margins, and profits. Net sales rose 10% to $5.66 million, driven mainly by medical markets. Gross margin expanded from 52% to 57%, lifting gross profit 21% to $3.21 million.
Operating income increased 86% to $897,000, while net income grew 53% to $741,000, or $0.05 per diluted share. Cash, cash equivalents, and marketable securities totaled $16.65 million with no debt, and backlog was $7.73 million. Management expects continued revenue growth and profitability in the first half of fiscal 2027, but only flat to modest revenue growth for the full year due to clean energy uncertainty and shipment timing for large systems.
Sono-Tek Corporation reported stronger profitability for fiscal 2026 despite modest revenue growth. Net sales for the year ended February 28, 2026 rose 2% to $20.9 million, but gross profit increased 8% to $10.6 million as gross margin expanded to 51% from 48%.
Operating income climbed 81% to $1.8 million and net income grew 42% to about $1.8 million, with diluted earnings per share at $0.11. Fourth quarter results were also stronger, with net sales up 10% to $5.6 million and net income up 70% to $0.6 million.
The company ended the year with $14.8 million in cash, cash equivalents and marketable securities and no debt, and reported an equipment and service backlog of approximately $9.12 million, up 5% and near record levels. Management expects continued revenue growth and profitability in the first half of fiscal 2027, while projecting total fiscal 2027 revenue to be relatively flat to modestly higher than 2026.
Sono-Tek Corporation filed a current report to notify investors that it has released a press release with its financial results for the quarter ended November 30, 2025. The press release is included as Exhibit 99.1 to the report and provides details on the company’s results of operations and financial condition for that quarter.
The company notes that the information in the furnished exhibit, including the press release, is being provided under Regulation FD and is not considered filed for liability purposes under the Securities Exchange Act. The report is signed by the company’s Chief Financial Officer, Stephen J. Bagley.
Sono-Tek Corporation furnished a press release announcing financial results for the quarter ended August 31, 2025. The company reported this under Item 2.02 and included Regulation FD disclosure under Item 7.01. The release is attached as Exhibit 99.1 and is designated as “furnished,” not “filed,” under the Exchange Act.
Sono-Tek Corporation reported via an 8-K that it issued a press release announcing an order for medical device coating systems valued at $2.8 million.
The disclosure was furnished under Item 2.02 (Results of Operations and Financial Condition) and Item 7.01 (Regulation FD Disclosure) and includes Exhibit 99.1, a press release dated October 13, 2025. The furnished information is not deemed filed under Section 18 of the Exchange Act.
Sono-Tek Corporation filed an 8-K announcing that it issued a press release with financial results for the quarter ended August 31, 2025. The release is furnished as Exhibit 99.1 and relates to Items 2.02 (Results of Operations and Financial Condition) and 7.01 (Regulation FD).
The company states the information furnished under Item 7.01, including Exhibit 99.1, is not deemed “filed” under Section 18 of the Exchange Act and is not incorporated by reference into other filings. The press release is dated October 14, 2025.
Sono-Tek Corporation reported that it issued a press release announcing an order for medical device coating systems valued at over $5 million. The company described this order in a report about its results of operations and financial condition and as a Regulation FD disclosure.
The press release, dated September 3, 2025 and attached as an exhibit, provides additional details on the order. The information in this report and the exhibit is being furnished rather than filed, meaning it is not subject to certain liability provisions of the securities laws or automatically incorporated into other company reports.
Sono-Tek Corporation shareholders elected four director nominees to serve until the 2026 annual meeting and ratified the appointment of CBIZ CPAs P.C. as independent auditors for the fiscal year ending February 28, 2026. Shareholders also approved, in a non-binding advisory vote, the compensation of the company’s named executive officers and recommended a three-year frequency for future non-binding shareholder votes on executive compensation, which the company accepted.
Sono-Tek Corporation filed a current report describing information shared at its annual meeting of shareholders. On August 21, 2025, the company provided a presentation at the meeting, which is furnished as Exhibit 99.1. The disclosure is made under the sections for results of operations and financial condition and for Regulation FD, but the materials are expressly treated as “furnished” rather than “filed,” meaning they are not subject to certain Exchange Act liabilities and are not automatically incorporated into other securities law filings.